Found 7 matching trials
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
PHASE1The purpose of this study is to compare the relative bioavailability of 3 m...
Location
PRACS Institute, Ltd.
Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Kendle International Inc.
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
PHASE1Study to evaluate if Xanax sustained release tablets manufactured at two di...
Location
Pfizer Investigational Site
Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Kendle International Inc.
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
PHASE1This study will compare the relative bioavailability (rate and extent of ab...
Location
PRACS Institute, Ltd.
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions
PHASE1This study will compare the relative bioavailability (rate and extent of ab...
Location
PRACS Institute, Ltd.
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
PHASE1The purpose of this study is to compare the relative bioavailability of 3 m...
Location
PRACS Institute, Ltd.